Skybiotech Healthcare Limited has issued a regulatory disclosure to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Friday, 14th August, 2026.

The primary agenda items for the board meeting include:

  • Consideration and approval of the Un-Audited financial results of the Company for the Quarter ended on June 30, 2026
  • Consideration and approval of the limited review report for the same quarter
  • Any other business with the permission of the chair

This intimation is made in compliance with Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015. The disclosure was signed by Poonam Prakash Rathi, Managing Director (DIN: 01274428), on behalf of the company.

The company's registered office is located at GUT No. 05, Gevrai Tanda, Paithan Road, Chh. Sambhaji Nagar (Aurangabad) MH 431002, with CIN L21001MH1983PLC031114.